ProQR Therapeutics (PRQR) Capital Expenditures (2013 - 2026)
ProQR Therapeutics (PRQR) posted Capital Expenditures of -$338,247 for the quarter ended Jun 30, 2026, compared with -$114,328 a year earlier.
ProQR Therapeutics (PRQR) Capital Expenditures (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at ProQR Therapeutics was -$1.34 million; for the year ended Dec 31, 2025, it came in at -$1.15 million.
- In prior years, ProQR Therapeutics' Capital Expenditures was -$1.53 million in the year ended Dec 31, 2024, -$1.48 million in the year ended Dec 31, 2023, -$746,201 in the year ended Dec 31, 2022 and -$572,764 in the year ended Dec 31, 2021.
- Quarterly Capital Expenditures has run from a low of -$795,217 in the quarter ended Mar 31, 2024 to a high of $13,263 in the quarter ended Dec 31, 2022 over five years.
- According to Business Quant data, Capital Expenditures for the three prior quarters was -$192,002 (quarter ended Mar 31, 2026), -$612,287 (quarter ended Dec 31, 2025) and -$197,570 (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | ProQR Therapeutics | 174.90 Mn | -288.70 Mn | - | -338,247.30 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -338,247.30 |
| Mar 31, 2026 | -192,002.29 |
| Dec 31, 2025 | -612,286.89 |
| Sep 30, 2025 | -197,570.31 |
| Jun 30, 2025 | -114,327.93 |
| Mar 31, 2025 | -235,622.11 |
| Dec 31, 2024 | -142,123.19 |
| Sep 30, 2024 | -314,090.78 |
| Jun 30, 2024 | -287,528.98 |
| Mar 31, 2024 | -795,216.81 |
| Dec 31, 2023 | -647,715.83 |
| Sep 30, 2023 | -369,032.17 |
| Jun 30, 2023 | -320,143.77 |
| Mar 31, 2023 | -145,974.49 |
| Dec 31, 2022 | 13,263.22 |
| Sep 30, 2022 | -248,035.49 |
| Jun 30, 2022 | -246,490.09 |
| Mar 31, 2022 | -273,850.40 |
| Dec 31, 2021 | -257,393.46 |
| Sep 30, 2021 | -206,375.28 |
ProQR Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRQR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();